James McGowan

800 total citations
10 papers, 351 citations indexed

About

James McGowan is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Complementary and alternative medicine. According to data from OpenAlex, James McGowan has authored 10 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 2 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Complementary and alternative medicine. Recurrent topics in James McGowan's work include Heart Failure Treatment and Management (9 papers), Cardiovascular Function and Risk Factors (7 papers) and Cardiac pacing and defibrillation studies (4 papers). James McGowan is often cited by papers focused on Heart Failure Treatment and Management (9 papers), Cardiovascular Function and Risk Factors (7 papers) and Cardiac pacing and defibrillation studies (4 papers). James McGowan collaborates with scholars based in United Kingdom and United States. James McGowan's co-authors include John G.F. Cleland, Nikolay P. Nikitin, Peter J. Cowburn, Theresa A. McDonagh, G. McCurrach, Roy S. Gardner, Simon Ray, William Martin, Malcolm I. Burgess and Ross McGeoch and has published in prestigious journals such as American Heart Journal, European Journal of Heart Failure and Journal of Cardiovascular Pharmacology.

In The Last Decade

James McGowan

10 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James McGowan United Kingdom 8 293 97 86 39 29 10 351
M Ornaghi Italy 8 295 1.0× 120 1.2× 108 1.3× 26 0.7× 25 0.9× 12 354
Nina Ghosh Canada 12 247 0.8× 64 0.7× 65 0.8× 50 1.3× 20 0.7× 26 366
Ara Sadaniantz United States 14 467 1.6× 99 1.0× 92 1.1× 11 0.3× 20 0.7× 38 547
Agata Puzzovivo Italy 9 247 0.8× 65 0.7× 88 1.0× 27 0.7× 16 0.6× 19 347
A McNeill United Kingdom 9 321 1.1× 265 2.7× 102 1.2× 26 0.7× 46 1.6× 19 403
Gregory Schnell Canada 7 356 1.2× 61 0.6× 74 0.9× 24 0.6× 65 2.2× 14 431
Masayuki Motohiro Japan 10 154 0.5× 75 0.8× 38 0.4× 43 1.1× 12 0.4× 20 345
Antonio Mantero Italy 9 311 1.1× 149 1.5× 49 0.6× 17 0.4× 18 0.6× 26 388
V. Oren Israel 9 281 1.0× 171 1.8× 91 1.1× 12 0.3× 31 1.1× 13 419
S. Prasad Australia 12 365 1.2× 203 2.1× 79 0.9× 13 0.3× 12 0.4× 58 464

Countries citing papers authored by James McGowan

Since Specialization
Citations

This map shows the geographic impact of James McGowan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James McGowan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James McGowan more than expected).

Fields of papers citing papers by James McGowan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James McGowan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James McGowan. The network helps show where James McGowan may publish in the future.

Co-authorship network of co-authors of James McGowan

This figure shows the co-authorship network connecting the top 25 collaborators of James McGowan. A scholar is included among the top collaborators of James McGowan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James McGowan. James McGowan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Heggie, Robert, Olívia Wu, Richard Good, et al.. (2023). The coronary microvascular angina cardiovascular magnetic resonance imaging trial: Rationale and design. American Heart Journal. 265. 213–224. 2 indexed citations
2.
Cleland, John G.F., Nikolay P. Nikitin, & James McGowan. (2004). Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure. Expert Review of Cardiovascular Therapy. 2(1). 9–19. 25 indexed citations
3.
McGowan, James & John G.F. Cleland. (2003). Reliability of reporting left ventricular systolic function by echocardiography: A systematic review of 3 methods. American Heart Journal. 146(3). 388–397. 209 indexed citations
4.
Cleland, John G.F. & James McGowan. (2002). Levosimendan: a new era for inodilator therapy for heart failure?. Current Opinion in Cardiology. 17(3). 257–265. 40 indexed citations
5.
Gardner, Roy S., James McGowan, & Theresa A. McDonagh. (2002). Left Ventricular Systolic Dysfunction in a Cardiac Transplant Recipient Treated with Carvedilol. European Journal of Heart Failure. 4(3). 377–379. 4 indexed citations
6.
McGowan, James, William Martin, Malcolm I. Burgess, et al.. (2001). Validation of an Echocardiographic Wall Motion Index in Heart Failure Due to Ischaemic Heart Disease. European Journal of Heart Failure. 3(6). 731–737. 10 indexed citations
7.
Cleland, John G.F. & James McGowan. (1999). Heart Failure due to Ischaemic Heart Disease: Epidemiology, Pathophysiology and Progression. Journal of Cardiovascular Pharmacology. 33. S17–S29. 31 indexed citations
8.
Cleland, John G.F. & James McGowan. (1999). Heart Failure due to Ischaemic Heart Disease: Epidemiology, Pathophysiology and Progression. Journal of Cardiovascular Pharmacology. 33(Supplement 3). S17–S29. 8 indexed citations
9.
McGowan, James, et al.. (1999). Carvedilol for Heart Failure: Clinical Trials in Progress. Heart Failure Reviews. 4(1). 89–96. 13 indexed citations
10.
Cleland, John G.F., James McGowan, & Peter J. Cowburn. (1998). β-Blockers for Chronic Heart Failure: From Prejudice to Enlightenment. Journal of Cardiovascular Pharmacology. 32. S52–S60. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026